Finance and markets: business, quotes, gold, energy and releases.
Found 26100 articles
David C. Kimbell, the former chief executive of Ulta Beauty, has joined the Board of Directors at Group 1 Automotive. His appointment, effective August 10, 2026, expands the board to ten members and places the veteran retail strategist directly onto the company's Audit Committee.
Convinced that public markets are undervaluing its infrastructure, Hyperscale Data, Inc. has launched a formal review of its strategic alternatives. The Las Vegas-based firm is now weighing a potential sale or lease of its Michigan data center, a move aimed at capturing value that leadership insists remains unrecognized by current stock prices.
A securities fraud class action has been filed against Capricor Therapeutics, targeting the company's disclosure practices regarding its lead drug candidate, Deramiocel. Investors who suffered losses between December 17, 2025, and July 26, 2026, are now being urged to step forward as the court considers a lead plaintiff.
A federal securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation, alleging the company artificially inflated sales figures through aggressive bulk-discount programs. Investors who purchased common stock between February 28, 2024, and February 25, 2026, are now being sought to serve as lead plaintiffs in the litigation.
Keenova Therapeutics reported a $221 million loss from continuing operations for the second quarter of 2026, a sharp decline from the prior year’s $31 million loss. Despite the deficit, the company raised its full-year growth outlook for core brands Acthar Gel and XIAFLEX, citing strong market demand.
DarioHealth reported second-quarter 2026 revenue of $5.2 million, a figure shaped by the company’s strategic exit from pharmaceutical-related services. Despite the top-line contraction, the AI-focused healthcare firm significantly improved its operational efficiency, cutting its quarterly operating loss by 11% compared to the start of the year.
With top-line data for its lead multiple sclerosis therapy expected by year-end, New York-based Immunic is restructuring its executive ranks. The biotech firm confirmed that its Phase 3 ENSURE trials remain on schedule, supported by a bolstered leadership team and a strengthened balance sheet following recent private financing.
Investors who purchased Primoris Services Corporation stock between August 5, 2025, and June 22, 2026, are seeking lead plaintiff status in a federal securities class action. The lawsuit alleges that company executives misled shareholders about the firm's ability to manage costs and risks within its renewable energy projects.
Investors who held Pentair plc stock during a period of significant volatility between April 28 and July 14, 2026, have until October 2 to apply for lead plaintiff status in a class action lawsuit, according to the legal firm Hagens Berman Sobol Shapiro LLP.
Duke Energy has priced a public offering of 35 million equity units at $50 apiece, aiming to raise $1.75 billion. The offering, slated to close on August 13, 2026, includes an over-allotment option for underwriters that could push the total proceeds to nearly $2 billion.
Investors holding Black Rock Coffee Bar stock face an August 17, 2026, deadline to seek lead plaintiff status in a class action lawsuit. The litigation targets the company over allegations that executives misled shareholders regarding the success of its expansion strategy following the firm's September 2025 Initial Public Offering.
Investors who purchased Cogent Communications Holdings stock between February 29, 2024, and May 1, 2026, have until September 21, 2026, to file as lead plaintiffs in a securities class action lawsuit questioning the company’s disclosures regarding its optical wavelength backlog and projected revenue growth.
A federal securities class action lawsuit now targets Regeneron Pharmaceuticals, alleging the company misled investors regarding the efficacy of a high-stakes melanoma therapy. The litigation follows a failed Phase 3 clinical trial that erased $11 billion in market capitalization and triggered a sharp decline in the company’s share price.
Investors who suffered losses in Embecta Corp. stock between November 25, 2025, and May 4, 2026, have until August 17, 2026, to file as lead plaintiffs. The class action suit centers on allegations that the company misled shareholders about the stability of its insulin pen needle business.
With nearly two decades of experience navigating complex digital transformations and regulatory landscapes, Hongyu Chen-Birkenbeul joins Vienna-based KuCoin EU as Managing Director. Her arrival signals a strategic push to bolster the MiCAR-licensed platform's technical infrastructure and operational resilience as the firm scales its footprint across the European Economic Area.
In Shenzhen, the Shoplazza DTC Summit 2026 marked a strategic pivot for the e-commerce platform, shifting from fragmented digital tools toward a unified, autonomous future. Founder and CEO Jeff Li showcased the latest evolution of Athena, an AI agent designed to manage complex storefront operations through natural language commands.
Thirty-nine percent of first-time buyers who regret their initial anal toy purchase cite a lack of personalized sizing data as the primary culprit. As the $39 billion sexual wellness market pivots toward AI-driven personalization, Lovense is abandoning generic industry advice in favor of a new, dimension-focused classification framework.
The convenience store aisle, once the domain of empty calories and impulse buys, is undergoing a profound shift in purpose. Driven by the rapid adoption of GLP-1 medications and a heightened focus on wellness, a new demographic of shoppers is transforming gas stations into hubs for functional, protein-rich nutrition.
With over 25 countries now utilizing its technology, Pleasanton-based n6 is aggressively broadening its global footprint. The company announced new distribution agreements today that extend the reach of its iconPCR and AutoNorm platforms deeper into Western Europe, the Middle East, and key African territories.
Institutional investors can now query decades of proprietary real estate research directly within ChatGPT, Claude, and Gemini. By launching a new Model Context Protocol (MCP) server, Newport Beach-based Green Street is embedding its private market intelligence into the existing workflows of commercial real estate professionals worldwide.
With the landscape of corporate oversight shifting under the pressure of artificial intelligence and geopolitical volatility, 50/50 Women on Boards has unveiled its speaker lineup for the 2026 Global Summit. The event, scheduled for September 17 at 48 Wall Street, centers on the theme of reforming corporate governance.
Seattle-based Jones Soda and Miami’s Rap Snacks are merging their respective expertise in craft beverages and music-driven consumer goods. The collaboration, announced August 11, 2026, aims to deliver a series of limited-edition sodas that celebrate the intersection of hip hop culture, entrepreneurship, and bold, artist-led flavor profiles.
Arctech is expanding its footprint in Central Asia with 425 MW of new solar tracker projects, split between a 325 MW installation in Kyrgyzstan and a 100 MW site in Kazakhstan. The expansion tests the company’s ability to deploy specialized mounting technology across notoriously difficult, frost-heave-prone terrain.
Turpaz Industries, a global developer of flavor and fragrance extracts, reported record financial results for the first half of 2026, with revenues climbing 40.5% to $173.9 million. The performance underscores the company’s aggressive acquisition strategy, which has integrated eight strategic businesses since early 2025 to bolster its international footprint.
Radiologists are notoriously difficult to reach through traditional recruitment channels, often ignoring generic career boards in favor of their specialized training environments. To bridge this gap, Charlotte-based Medality has launched a dedicated job board integrated directly into the professional education platform used by over 40,000 active subscribers.
Patients in South Los Angeles are currently being treated in parking lot tents as emergency volumes soar five times beyond capacity. To address this crisis, Kaiser Permanente has pledged $32 million to expand the Hope Emergency Center at Martin Luther King Jr. Community Hospital, marking the largest donation in the facility's history.
Surgeons in the United States now have access to the BAGUERA C cervical disc prosthesis following its FDA approval for one and two contiguous levels. This decision introduces a motion-preserving alternative to traditional spinal fusion, backed by nearly two decades of international clinical data and extensive human trials.
As mass consolidation reshapes the financial landscape, Cambridge Investment Research has attracted 189 new advisors during the first half of 2026. These recruits brought $6.8 billion in new assets under advisement and $55.9 million in annualized revenue, signaling a distinct shift toward firms that emphasize independence over mega-mergers.
Marking eight decades of pharmaceutical production in Italy, Cambrex has broken ground on a $30 million research facility at its Milan site. The expansion aims to bolster the company’s analytical and process development capabilities, positioning the legacy location to handle increasingly complex small molecule drug therapies for its global clientele.
As compensation begins to reach survivors of the MacLaren Children's Center abuse scandal, Legal Bay LLC has launched a funding program to advance future installment payments. The initiative aims to provide immediate liquidity to plaintiffs who otherwise face a five-year wait for their full court-ordered settlements from Los Angeles County.